Zivo Bioscience (ZIVO) Stock Statistics & Valuation Metrics

Zivo Bioscience has a market cap or net worth of $37.91M. The enterprise value is $38.31M.

Zivo Bioscience has 3,888,595 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zivo Bioscience’s return on equity (ROE) is 26.00 and return on invested capital (ROIC) is 5128.62%.

The current PE Ratio of Zivo Bioscience is ―. Zivo Bioscience’s PEG ratio is 0.37.

In the last 12 months, Zivo Bioscience had revenue of 157.22K and earned -13.38M in profits. Earnings per share was -3.92.

In the last 12 months, operating cash flow was -3.08M and capital expenditures 0.00, giving a free cash flow of -3.08M billion.

Zivo Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Zivo Bioscience upcoming earnings date is ―, ―.

Zivo Bioscience as a current ratio of 0.80, with Debt / Equity ratio of -31.64%

In the past 12 months, Zivo Bioscience has paid 0.00 in taxes.

Zivo Bioscience EV to EBITDA ratio is -5.39, with an EV/FCF ratio of -16.70.

Zivo Bioscience has $57.22K in cash and marketable securities with $1.04M in debt, giving a net cash position of -$982.60K billion.

Gross margin is 31.68%, with operating margin of -8498.85%, and net profit margin of -8513.44%.

The average price target for Zivo Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Hold